diagram of anabolicum-vister
Anabolicum Vister, sold as the drug Quinbolone, is an oral steroid compound designed to be non-toxic to the liver. Unfortunately, positive results are only experienced with high doses and it is much more effective to shoot a similar compound, such as Boldenone.
Although you need high doses, Anabolic Vister will still produce some results in muscle gain, fat loss and even bolster red cell production and without the toxic effect on the liver and minimal conversion to estrogen.
Anabolicum Vister (Quinbolone) Profile
Anabolicum Vister, known as Quinbolone, is an anabolic steroid developed in the 1970s as an alternative to traditional oral steroids. It was designed to be a non-toxic, orally active compound that converted into the active hormone boldenone in the body. Unlike other anabolic steroids, Quinbolone was intended to offer muscle-building benefits with minimal androgenic side effects.
Due to its unique structure, Quinbolone has a relatively mild anabolic profile compared to stronger steroids like Dianabol or Winstrol. It promotes lean muscle growth, enhanced nitrogen retention, and improved protein synthesis, making it useful for athletes seeking gradual, quality gains without excessive water retention or bloating. Additionally, it has been noted for its mild impact on the liver, reducing the risk of hepatotoxicity associated with many oral anabolic steroids.
Despite its potential advantages, Quinbolone never gained widespread popularity in bodybuilding due to its relatively weak anabolic potency. Many users found that they needed high doses to achieve noticeable effects, making it less efficient compared to injectable alternatives like Boldenone Undecylenate (Equipoise).
Quinbolone was eventually discontinued and is rarely seen in modern performance-enhancing circles. However, its development highlighted the potential for safer oral steroids with reduced toxicity, paving the way for further research into alternative anabolic compounds.
Quinbolone was eventually discontinued and is rarely seen in modern performance-enhancing circles. However, its development highlighted the potential for safer oral steroids with reduced toxicity, paving the way for further research into alternative anabolic compounds.
